
Amanta Healthcare Ltd is Rated Sell
2026-11-21 10:10:47Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAmanta Healthcare Ltd Falls 4.89%: 5 Key Factors Driving the Weekly Decline
2026-11-21 10:00:09Key Events This Week 16 Nov: Sharp decline of 6.32% to Rs.220.25 on heavy volume 17 Nov: New 52-week and all-time high at Rs.243.1 and Rs.242.90 respectively 18 Nov: Further 52-week and all-time highs at Rs.245.6 and Rs.244.00 amid sector outperformance 19 Nov: Modest gains continue with Rs.238.95 close (+0.93%) 20 Nov: Sharp sell-off of 6.42% to close the week at Rs.223.60 Week Open</di...
Read More
Broad-Based Technical Strength Lifts Amanta Healthcare Ltd to 52-Week High of Rs 245.6
2026-11-18 10:44:50With a near doubling in price from Rs 93.1 to Rs 245.6 over the past year, Amanta Healthcare Ltd has surged to a fresh 52-week and all-time high on 18 Nov 2026, powered by a strong alignment of technical indicators and sustained price momentum.
Read More
Strong Momentum Meets Stretched Valuations as Amanta Healthcare Ltd Reaches All-Time High
2026-11-18 10:24:25Amanta Healthcare Ltd has surged to a fresh all-time high of Rs 243.7 on 18 Nov 2026, extending its recent winning streak and significantly outpacing the broader market. This milestone caps a remarkable run that has seen the stock more than double over the past year, raising questions about the sustainability of its current momentum amid stretched valuation metrics.
Read More
Broad-Based Technical Strength Lifts Amanta Healthcare Ltd to 52-Week High of Rs 243.1
2026-11-17 10:39:39Surging past its previous peaks, Amanta Healthcare Ltd touched a fresh 52-week high of Rs 243.1 on 17 Nov 2026, marking a remarkable 93.45% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment that has seen the Sensex rally steadily over recent weeks.
Read More
Strong Momentum Meets Stretched Valuations as Amanta Healthcare Ltd Reaches All-Time High
2026-11-17 10:14:19Amanta Healthcare Ltd surged 10.28% on 17 Nov 2026, touching an all-time high near Rs 242.90, significantly outpacing the Sensex’s modest 0.41% gain. This rally extends a remarkable upward trajectory that has seen the stock nearly double over the past year, raising questions about the sustainability of its current momentum amid stretched valuation metrics.
Read MoreAmanta Healthcare Gains 20.32%: 7 Key Factors Driving the Surge
2026-11-14 09:01:45Key Events This Week Nov 09: Stock opens strong at Rs.202.60 (+3.68%) Nov 11: Technical momentum shifts amid mixed signals; price dips to Rs.195.25 (-3.63%) Nov 12: New 52-week and all-time highs at Rs.227 and Rs.211 respectively; stock surges 17.06% Nov 13: Hits fresh 52-week and all-time high at Rs.236; closes at Rs.235.10 (+2.87%) Week Open Rs.195.40...
Read More
Amanta Healthcare Ltd Hits All-Time High of Rs 236 as Momentum Builds Across Timeframes
2026-11-13 09:37:35Extending its recent rally, Amanta Healthcare Ltd surged to a fresh all-time high of Rs 236 on 13 Nov 2026, outperforming the broader Sensex which declined by 0.32% on the day. This milestone caps a remarkable run where the stock has gained over 20% in just two sessions, reflecting strong buying interest and positive momentum across multiple timeframes.
Read More
Broad-Based Technical Strength Lifts Amanta Healthcare Ltd to 52-Week High of Rs 227
2026-11-12 11:12:02Surging to an all-time high of Rs 227 on 12 Nov 2026, Amanta Healthcare Ltd has demonstrated remarkable price momentum, outperforming its sector by 13.33% in a single session. This milestone caps an impressive 80.31% rally over the past year, dwarfing the Sensex’s modest decline of 2.78% during the same period.
Read MoreSubmission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 - Off Market Transfer Of Equity Shares
18-Nov-2026 | Source : BSEsubmission of Disclosures under Regulation 7(2) of The SEBI (Prohibition of Insider Trading) Regulations 2015 - off-market transfer of equity shares
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
18-Nov-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vishal Ashokkumar Patel
Company Response On The Spurt In Volume Of Security Across Exchanges
14-Nov-2026 | Source : BSECompany Response On The Spurt In Volume Of Security Across Exchanges
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available